Elsevier Launches New Open Access Journal: Leukemia Research Reports
OXFORD, England, November 22, 2012 /PRNewswire/ –
A new forum for short communications of clinical research in leukemias,
lymphomas, multiple myeloma and other hematologic malignancies
Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and solutions, is pleased to announce the launch of a new
open access, online journal, Leukemia Research Reports.
Leukemia Research Reports, a sister journal to the prestigious publication Leukemia
Research, will deliver timely information online to all health care professionals involved
in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and
other hematologic malignancies. It will fulfill this role by rapidly publishing a range of
peer-reviewed short form papers, including brief communications, case reports, letters to
the editors, images and debate articles.
The editors of Leukemia Research Reports are: Dr Suneel Mundle (Janssen Services LLC
and Rush Medical College, Chicago, IL) and Dr Meir Wetzler (State University of New York
at Buffalo School of Medicine and Roswell Park Cancer Center, Buffalo, NY).
The editors encourage the submission of articles relevant to normal and leukemic
hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as
epidemiologic and clinical studies. Coverage will encompass the application of oncogenes,
genomics (gene expression profiles, microRNAs), proteomics growth factors, cell markers,
cell cycle and differentiation agents, novel therapeutics and clinical trials in both the
acute and chronic leukemias as well as the myelodysplastic syndromes. In addition articles
are solicited on the rapidly growing specialty of marrow or stem cell reconstitution after
high dose therapy with curative attempt in patients with a wide range of neoplasms.
For more information or to submit an article, go to
http://www.journals.elsevier.com/leukemia-research-reports. First articles published
in the journal are now available online through ScienceDirect.
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], ClinicalKey
[http://www.clinicalkey.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Rachel Garland Elsevier +44(0)1865-843113 email@example.com